%A Wang Haohua, Chen Xiuxing, Guo Guifang %T exokinaseⅡ role in tumor growth and targeting therapyW %0 Journal Article %D 2017 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673422X.2017.03.014 %P 213-216 %V 44 %N 3 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10179.shtml} %8 2017-03-08 %X The energy for tumor cells mainly derives from the aerobic glycolysis, that is, the Warburg effect, which also provides a large amount of precursor substances for the growth of tumor cells. HexokinaseⅡ (HKⅡ), highly expressed in tumor tissue, is the ratelimiting enzyme of glycolysis and closely related to the energy metabolism of tumor. Recent studies have showed that HKⅡ not only mediates Warburg effect, but also promotes tumor proliferation by inhibiting tumor cell apoptosis and regulating autophagy. It has been confirmed that blocking HKⅡ gene expression and inhibiting HKⅡ with small molecule inhibitor can kill tumor cells in many kinds of cancer. Agent targeting HKⅡ may become a new generation of targeted drugs.